Geneva (October 6, 2025) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce a complimentary webinar, ‘Ensuring Patient Safety: Analytical Strategies for Nitrosamines & Genotoxic Impurities’, on October 21, 2025.
Nitrosamines and other genotoxic impurities present a significant challenge to the pharmaceutical industry, as even trace levels can pose serious safety risks to patients. Detecting and controlling these impurities requires rigorous scientific, regulatory and manufacturing strategies to ensure product quality and compliance.
In this webinar, expert presenters Dr Romain Simon and Paresh Thanki will provide a comprehensive overview of nitrosamine and genotoxic impurity management. Key topics include the importance of nitrosamine drug screening for patient safety, the influence of storage conditions and large-scale testing on N-Nitrosodibutylamine (NDBA) contamination and best practice strategies for nitrosamine mitigation. Practical approaches and real-world case studies will be highlighted to strengthen regulatory compliance and product quality.
Agenda:
– Introduction
– Drug substance and product testing – why nitrosamine screening matters and effective mitigation strategies
– NDBA contamination – impact of storage conditions and the role of large-scale testing
– Q&A
This session is designed for pharmaceutical professionals seeking to enhance their understanding of impurity risks and regulatory expectations, including QC/QA managers, analytical chemists, production and process managers, R&D scientists and specialists from biotech firms, CROs, academic institutions, and regulatory bodies.
Pharmaceutical professionals looking to get the inside track on nitrosamine and genotoxic impurity management should register now for this free webinar.
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).